Accurate Wealth Management LLC acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during the ...
Shares of Boston Scientific Co. (NYSE:BSX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty ...
Bolt Acquisition Deal Drives BSX Stock Close to 52-Week High Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently ...
Citi analyst Joanne Wuensch maintained a Hold rating on Nevro Corp (NVRO – Research Report) today. The company’s shares closed yesterday at ...
Dr. Greg Vigna Spinal cord stimulators are linked to over 80,000 injuries, with lead migration and hematomas causing severe harm <b ...
RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Nevro Corp (NVRO – Research Report) on January 13 and set a price target of ...
A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.
Since the first brain implant about a year ago, Musk said the company has upgraded the devices with more electrodes, higher ...
CEO Dave Marver to Provide Company Update Wednesday, January 15, 2025 Wednesday, January 15 at 1:30pm Eastern Time (10:30am Pacific Time / 7:30pm Central European Time). The Company presentation and Q ...
Onward Medical today announced the first commercial sales of its ARC-EX spinal cord stimulation system (SCS) in the U.S.